Search - tctmd.com

Displaying 481 - 500 of 562

Sort: Relevancy | Date

Presentation TCT 2014

Randomized Controlled Trials I: New Insights From INPACT SFA II

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, John R. Laird Jr

September 15, 2014

Presentation TCT 2014

DCB in De Novo Lesions: Critical Review of FIH Data, Efficacy, and Long-term Durability

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

Ultrasound-Facilitated Drug-Coated Balloons: Powering the Future?

Presenter: John R. Laird Jr, Daniel J. McCormick, Dmitriy N. Feldman, Craig M. Walker

September 13, 2014

Presentation TCT 2014

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Yelin Zhao

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

Presentation TCT 2014

Approach to In-Stent Restenosis in 2014: DCB or DES?

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Robert A. Byrne

September 13, 2014

Presentation TCT 2014

Acute Coronary Syndromes (Including STEMI)

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Bruno Scheller

September 13, 2014

Presentation TCT 2014

Small Vessel, Diabetic, and Diffuse Disease

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Paul JL Ong

September 13, 2014

Presentation TCT 2014

Bifurcations: Technical Approach and Clinical Results

Presenter: Azeem Latib, Ron Waksman, Ronald Caputo, Thomas A. Ischinger, Kenneth Chin

September 13, 2014

Presentation TCT 2014

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Azeem Latib

September 13, 2014

Presentation TCT 2014

DCB Plus Adjunctive Stenting: Technique and Clinical Results

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Jochen Wöhrle

September 13, 2014

Presentation TCT 2014

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Raban Jeger

September 13, 2014

Presentation TCT 2014

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Sahil A. Parikh

September 13, 2014

Presentation TCT 2014

DCB is a Useful Ancillary Tool but Unlikely to Become a Work-Horse Technology!

Presenter: Antonio Colombo

September 13, 2014

Presentation TCT 2014

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

Presenter: Franz X. Kleber

September 13, 2014

Presentation TCT 2014

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

Presenter: Robert A. Byrne, Bruno Scheller, Francesco Liistro, Tudor C Poerner

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Industry News

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

September 10, 2014

News Industry News

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

July 14, 2014

News Daily News

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

L.A. McKeown

June 17, 2014

Advertisement

Randomized Controlled Trials I: New Insights From INPACT SFA II

DCB in De Novo Lesions: Critical Review of FIH Data, Efficacy, and Long-term Durability

Ultrasound-Facilitated Drug-Coated Balloons: Powering the Future?

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Approach to In-Stent Restenosis in 2014: DCB or DES?

Acute Coronary Syndromes (Including STEMI)

Small Vessel, Diabetic, and Diffuse Disease

Bifurcations: Technical Approach and Clinical Results

DCB Plus Provisional Scaffold (BRS): Technique and Clinical Results

DCB Plus Adjunctive Stenting: Technique and Clinical Results

DCB Only Followed by Provisional Stenting: Insights from BASKET-SMALL 2 Trial

Technique Strategy Selection: A Critical Review of International Consensus Group Position Papers

DCB is a Useful Ancillary Tool but Unlikely to Become a Work-Horse Technology!

The DCB-Only Approach Is Feasible: The Real Promise to Leave Nothing Behind!

DCB ONLY and Vascular Restoration: Insights from Intracoronary OCT Human Studies

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Boston Scientific Announces Schedule For Presentations At Upcoming TCT 2014

Boston Scientific Receives CE Mark For Ranger™ Drug-Coated Balloon

Un Panel Asesor de la FDA Aprueba un Balón recubierto de Paclitaxel para el Manejo de la Enfermedad Femoropoplítea

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content